What the company does
Orexo AB (publ), a pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; Edluar for the treatment of insomnia; and Diabact UBT for the treatment of diagnosis of Helicobacter pylori. The company is developing Izipry for opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; OX390 for overdoses caused by a combination of life-threatening illicit drugs; OX125 for opioid …
What the weekly tape is saying
ORX closed the latest completed week at 20.70 SEK. The 4-week return is 12.0% and the 12-week return is -7.0%. Trend Signal is inactive, Market Dynamics is -0.80. Setup signature: Risk-first tape with a 27/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 24.60 SEK
- Vs Trend Line
- -15.9%
- Fair Value
- 19.03 SEK
- Vs Fair Value
- 8.8%
- 52W High
- 43.40 SEK
- 52W Low
- 17.50 SEK
- Drawdown
- -52.3%
- Range Position
- 12.4%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 32
- 52W Active Breadth
- 61.5%
- Sector Scope
- SE Healthcare
- Sector Rank
- 17 of 158
- Sector Percentile
- 89.8%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
SE Healthcare
- Tracked Peers
- 100
- 4W Rank
- 15 of 100
- Avg 1W
- 2.8%
- Avg 4W
- 1.2%
- Trend Breadth
- 29.0%
- Positive MD
- 69.0%
SE Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 19
- 4W Rank
- 6 of 19
- Avg 1W
- 3.4%
- Avg 4W
- 5.3%
- Trend Breadth
- 36.8%
- Positive RS
- 26.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.80
- 4W MD Change
- 44.8%
- Relative Strength
- -24.37
- 4W RS Change
- 21.4%
- Expectation
- Undecided
- Probability
- 48.69%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 105.5K
- 13W Average
- 226.5K
- 52W Average
- 289.4K
- Vs 13W
- 0.5x
- Vs 52W
- 0.4x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 5.1%
- 52W Volatility
- 9.1%
- Upside Weeks
- 22
- Downside Weeks
- 28
- Downside Breadth
- 53.8%
- Avg Gain / Loss
- 7.8% / -5.1%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- STO
- Country
- SE
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- SEK
- Market Cap
- 721.9M
Opportunity signals
- Price is above Fair Value, showing premium demand versus the model.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 20.70 SEK | 9.1% | 24.60 SEK | 19.03 SEK | -0.80 | -24.37 | 105.5K | Off |
| 5 Jun 2026 | 18.98 SEK | -7.4% | 24.84 SEK | 18.96 SEK | -1.10 | -30.91 | 189.1K | Off |
| 29 May 2026 | 20.50 SEK | 2.9% | 25.13 SEK | 18.89 SEK | -1.19 | -26.10 | 319.8K | Off |
| 22 May 2026 | 19.92 SEK | 7.8% | 25.37 SEK | 18.83 SEK | -1.38 | -28.26 | 217.0K | Off |
| 15 May 2026 | 18.48 SEK | 0.0% | 25.64 SEK | 18.77 SEK | -1.45 | -31.03 | 55.5K | Off |
| 8 May 2026 | 18.48 SEK | -2.0% | 26.33 SEK | 18.72 SEK | -1.37 | -31.77 | 188.4K | Off |
| 1 May 2026 | 18.86 SEK | -6.6% | 27.08 SEK | 18.67 SEK | -1.30 | -30.08 | 297.6K | Off |
| 24 Apr 2026 | 20.20 SEK | -3.8% | 27.74 SEK | 18.61 SEK | -1.29 | -26.07 | 236.1K | Off |
| 17 Apr 2026 | 21.00 SEK | 0.2% | 28.01 SEK | 18.56 SEK | -1.17 | -24.99 | 219.4K | Off |
| 10 Apr 2026 | 20.95 SEK | -5.8% | 28.28 SEK | 18.51 SEK | -1.14 | -23.32 | 276.3K | Off |
| 3 Apr 2026 | 22.25 SEK | -0.4% | 28.42 SEK | 18.47 SEK | -1.07 | -14.49 | 219.0K | Off |
| 27 Mar 2026 | 22.35 SEK | 0.4% | 28.46 SEK | 18.42 SEK | -1.03 | -10.82 | 497.8K | Off |
| 20 Mar 2026 | 22.25 SEK | -6.7% | 28.41 SEK | 18.37 SEK | -0.87 | -10.83 | 122.7K | Off |
| 13 Mar 2026 | 23.85 SEK | -6.1% | 28.36 SEK | 18.33 SEK | -0.68 | -8.88 | 183.1K | Off |